Literature DB >> 22411273

Investigations of potential susceptibility toward formaldehyde-induced genotoxicity.

Jasmin Zeller1, Josef Högel, Regina Linsenmeyer, Christopher Teller, Günter Speit.   

Abstract

Blood samples were taken from three groups of volunteers (30 male smokers, 30 female non-smokers, and 30 school children) and tested for ex vivo susceptibility toward formaldehyde (FA)-induced genotoxicity. Blood samples were exposed to 150 μM FA for 2 h, and the induction of DNA-protein crosslinks (DPX) in leukocytes was measured by a modification of the alkaline comet assay (i.e., reduction of γ-irradiation induced DNA migration). Removal of DPX was determined by the abolition of FA-induced reduction in DNA migration within 4 h after the end of the exposure. Induction and persistence of FA-induced DNA lesions was also measured by the sister chromatid exchange (SCE) test with cultured lymphocytes after treatment of whole blood cultures with FA (150 μM). Furthermore, the expression (mRNA level) of the GSH-dependent formaldehyde dehydrogenase (FDH, identical to alcohol dehydrogenase 5; ADH5) was measured in leukocytes by quantitative real-time RT-PCR with TaqMan probes. The subjects were also analyzed for the GSTM1 and GSTT1 metabolic gene polymorphisms and a correlation analysis with the investigated genetic endpoints for FA-induced genotoxicity was performed. The results indicate that there are no biologically relevant differences between the three study groups with regard to the various indicators of cellular sensitivity toward FA-induced genotoxic effects and the expression of FDH. The induced genotoxic effects were not associated with polymorphisms in GSTM1 and GSTT1. None of the study groups showed particular mutagen sensitivity toward FA-induced genotoxicity. These results suggest that a low scaling factor to address possible human inter-individual differences in FA-induced genotoxicity could be reasonable.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22411273     DOI: 10.1007/s00204-012-0830-6

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  7 in total

Review 1.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

2.  Formaldehyde Crosses the Human Placenta and Affects Human Trophoblast Differentiation and Hormonal Functions.

Authors:  Guillaume Pidoux; Pascale Gerbaud; Jean Guibourdenche; Patrice Thérond; Fatima Ferreira; Christelle Simasotchi; Danièle Evain-Brion; Sophie Gil
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

Review 3.  Recent trend in risk assessment of formaldehyde exposures from indoor air.

Authors:  Gunnar Damgård Nielsen; Søren Thor Larsen; Peder Wolkoff
Journal:  Arch Toxicol       Date:  2012-11-21       Impact factor: 5.153

4.  New results on formaldehyde: the 2nd International Formaldehyde Science Conference (Madrid, 19-20 April 2012).

Authors:  Hermann M Bolt; Peter Morfeld
Journal:  Arch Toxicol       Date:  2012-11-09       Impact factor: 5.153

5.  Bone marrow injury induced via oxidative stress in mice by inhalation exposure to formaldehyde.

Authors:  Yuchao Zhang; Xudong Liu; Cliona McHale; Rui Li; Luoping Zhang; Yang Wu; Xin Ye; Xu Yang; Shumao Ding
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

6.  Improved genotyping of N-acetyltransferase 2: role of the ultra-slow acetylators.

Authors:  Meinolf Blaszkewicz
Journal:  EXCLI J       Date:  2013-12-05       Impact factor: 4.068

Review 7.  Re-evaluation of the WHO (2010) formaldehyde indoor air quality guideline for cancer risk assessment.

Authors:  Gunnar Damgård Nielsen; Søren Thor Larsen; Peder Wolkoff
Journal:  Arch Toxicol       Date:  2016-05-21       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.